PATH vs SINT
Uipath Inc (PATH) versus SINTX Technologies Inc (SINT) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
SINTX Technologies Inc (SINT) is a medical devices company listed on US.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported SINT revenue for 2024-12-31 was $2.9M. Net income was -$11.0M. Revenue was up 9.9% from 2023-12-31 to 2024-12-31. SINT currently screens at market cap $12.6M.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. SINT currently screens at market cap $12.6M.
Not investment advice. Open the PATH and SINT stock pages for the full models.
Not investment advice.